NAQC Publishes 2014 Update to Medications Quality Improvement Initiative Issue Paper
Tuesday, June 24, 2014
Posted by: Natalia Gromov
Integration of Tobacco
Cessation Medications in State and Provincial Quitlines: A Review of the
Evidence and the Practice with Recommendations (2014 Update)
Dear Colleagues,
The purpose of this NAQC Quality Improvement Initiative Issue Paper is to
provide an update on the comprehensive review of the literature and practice
related to the integration of tobacco cessation medications and quitline
services that reflects additions to the evidence base and improvements in
practice since the first publication (2009). The author discusses the major
factors that must be considered in deciding if medications should be offered as
part of quitline services, including topics such as cost-effectiveness
analysis, choice of medication, determination of quantity of medication to
provide and the method of distribution of medications that will be used. A new
section on e-cigarettes appears in the update, as well as new content related to
concurrent use of more than one type of tobacco to reflect the FDA’s new
warning label regulations. Updated recommendations on key issues related to
integration of medications into quitline services are provided by the author.
Please find the new paper located on the Issue Paper page and make sure to join us for the upcoming
webinar on June 26, wherethe issue paper’s author, Ken Wassum,
reviews the update and its recommendations to quitlines and two states share
their experiences offering medications via their quitline.
|
|
Email to a Friend